Effects of Blocking D2/D3 Receptors on Mismatch Negativity and P3a Amplitude of Initially Antipsychotic Naïve, First Episode Schizophrenia Patients

Effects of Dopamine D2/D3 Blockade on Human Sensory and Sensorimotor Gating in Initially Antipsychotic-Naive, First-Episode Schizophrenia Patients

(2014) Signe Düring et al.   NEUROPSYCHOPHARMACOLOGY

Effect of Aripiprazole on Mismatch Negativity (MMN) in Schizophrenia

(2013) Zhenhe Zhou et al.   PLoS One

Comorbid substance abuse in first-episode schizophrenia: Effects on cognition and psychopathology in the EUFEST study

(2013) T. Wobrock et al.   SCHIZOPHRENIA RESEARCH

Mismatch Negativity: Translating the Potential

(2013) Juanita Todd et al.   Frontiers in Psychiatry

Clonidine Normalizes Sensorimotor Gating Deficits in Patients With Schizophrenia on Stable Medication

(2012) Bob Oranje et al.   SCHIZOPHRENIA BULLETIN

Alterations of mismatch negativity (MMN) in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness

(2012) Derek J. Fisher et al.   SCHIZOPHRENIA RESEARCH

Duration Mismatch Negativity and P3a in First-Episode Psychosis and Individuals at Ultra-High Risk of Psychosis

(2011) Rebbekah J. Atkinson et al.   BIOLOGICAL PSYCHIATRY

Automatic sensory information processing abnormalities across the illness course of schizophrenia

(2011) C. Jahshan et al.   PSYCHOLOGICAL MEDICINE

Dexamphetamine-induced reduction of P3a and P3b in healthy participants

(2010) Matthew A Albrecht et al.   JOURNAL OF PSYCHOPHARMACOLOGY

MMN responsivity to manipulations of frequency and duration deviants in chronic, clozapine-treated schizophrenia patients

(2010) Jemeen Horton et al.   SCHIZOPHRENIA RESEARCH

A single high dose of escitalopram increases mismatch negativity without affecting processing negativity or P300 amplitude in healthy volunteers

(2009) M. Wienberg et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: An open randomized clinical trial (EUFEST)

(2009) Han Boter et al.   SCHIZOPHRENIA RESEARCH

Are Auditory-Evoked Frequency and Duration Mismatch Negativity Deficits Endophenotypic for Schizophrenia? High-Density Electrical Mapping in Clinically Unaffected First-Degree Relatives and First-Episode and Chronic Schizophrenia

(2008) Elena Magno et al.   BIOLOGICAL PSYCHIATRY

Central auditory dysfunction in schizophrenia as revealed by the mismatch negativity (MMN) and its magnetic equivalent MMNm: a review

(2008) Risto Näätänen et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Deviant Matters: Duration, Frequency, and Intensity Deviants Reveal Different Patterns of Mismatch Negativity Reduction in Early and Late Schizophrenia

(2007) Juanita Todd et al.   BIOLOGICAL PSYCHIATRY